Adam Scott Levy Receives Stock Award at Mineralys Therapeutics Inc (MLYS) — SEC Form 4, Feb 24, 2025
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
6 business days
late vs 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Adam Scott Levy CIK 0001693134 |
CFO
|
Adam Scott Levy at Mineralys Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$5,709,439
More from this insider at Mineralys Therapeutics Inc
| 2026-02-20 | Award | — | View |
| 2026-01-13 | Sell | -$345,723 | View |
| 2025-11-13 | Sell | -$5,363,716 | View |
| 2025-10-15 | Sell | -$451,984 | View |
| 2025-07-31 | Sell | -$1,077,476 | View |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $10.20 | 2025-02-13 | A - Award/Grant | 170,000 A | $0.00 | 2035-02-13 | 170,000 Common Stock | Direct |
Footnotes (1)
- F1
- The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month anniversary following the date of grant. Show more
Related filings at Mineralys Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
225
institutional managers reporting a position
Largest by reported value
- Catalys Pacific, Llc $213M
- Ra Capital Management, L.P. $208M
- Black Rock, Inc. $159M
5%+ Holders · 13D/G
5 filers
-
Fmr Llc 5.1%
-
Catalys Pacific Fund, LP 10.1%
-
Black Rock, Inc. 5.2%
Other insiders at Mineralys Therapeutics Inc
-
Jon Congleton -$1.91M
-
Brian Taylor Slingsby -$3.01M
-
Eric Warren -$209K
GET /v1/forms/4/0001933414-25-000020
API docs
View Original SEC Filing